BP000227-C325: Recombinant Human Osteoprotegerin
Source: HEK 293-derived.
Purity > 95%, by reducing SDS-PAGE and SEC-HPLC.
Endotoxin: Less than 0.1 ng/ug (1 EU/ug).BP000227-CYT-266: Recombinant Human Osteoprotegerin/Fc Chimera
Source: Pichia Pastoris-derived.
Contains 412 amino acid residues, including 180 residues from mature OPG (a.a 22-201) and 232 residues from the Fc protein of human IgG1, and has a calculated molecular mass of 46.5 kDa.
Determined by its ability to neutralize the stimulation of U937 cells treated with 10 ug/ml of soluble RANKL (sRANKL) corresponding to a Specific Activity of 100,000 IU/mg.
Purity > 90%, by SDS-PAGE and RP-HPLC.BP000227-CYT-290: Recombinant Human Osteoprotegerin, His Tag
Source: E. coli-derived.
A single, non-glycosylated, polypeptide chain containing amino acids 201-401 and having a molecular mass of 31 kDa which includes a 4 kDa His tag.
Purity > 80%, by SDS-PAGE and RP-HPLC.
Applications: Positive control for Western blot; Antibody production; Protein assay.BP000227-CYT-633: Recombinant Human Osteoprotegerin, Hi-5
Source: Hi-5-derived.
A signle, glycosylated polypeptide chain containing 398 amino acid residues (22-401 a.a.), having a calculated molecular mass of 45.6 kDa.
Purity > 85%, by SDS-PAGE.BP000051-GD14: Recombinant Human OPG-Fc Fusion Protein
Source: HEK 293-derived.
The Osteoprotegerin / OPG / TNFRSF11B / OCIF / OBF activity is calculated by its ability to inhibit TRAIL-mediated cytotoxicity using L929 mouse fibrosarcoma cells treated with TRAIL. The ED50 for this effect is typically 5 ng/ml.
Endotoxin: < 5.0 EU per 1 ug of the protein by the LAL method.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000051-C325: Recombinant Human Tumor Necrosis Factor Receptor Superfamily Member 11B (TNFRSF11B) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).